Recombinant cytokines from plants

International Journal of Molecular Sciences

Volumn 12, Issue 6, 2011, Pages 3536-3552

  Sirko, Agnieszka ^a   Vaněk, Tomas ^b   Góra Sochacka, Anna ^a   Redkiewicz, Patrycja ^a  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b INSTITUTE OF EXPERIMENTAL BOTANY   (Czech Republic)

Author keywords

Cytokines; Interleukins; Molecular farming; Pharmaceutical proteins; Plant based production systems; Transgenic plants

Indexed keywords

ALPHAN3 INTERFERON; BETA1A INTERFERON; CARDIOTROPHIN 1; CONSENSUS INTERFERON; GAMMA1B INTERFERON; INTERFERON BETA SERINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT CYTOKINE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 4; RECOMBINANT SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; RECOMBINANT PROTEIN;

ARABIDOPSIS; CARROT; CELL PROLIFERATION; CUCUMBER; DRUG ACTIVITY; DRUG SYNTHESIS; HUMAN; LETTUCE; NONHUMAN; POTATO; REVIEW; RICE; SQUASH; SUGARCANE; TOBACCO; TOMATO; BIOSYNTHESIS; GENETICS; METABOLISM; PLANT; TRANSGENIC PLANT;

ANIMALIA;

CYTOKINES; HUMANS; PLANTS; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS;

EID: 79959717836     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12063536     Document Type: Review

References (66)

1. Barta, A.; Sommergruber, K.; Thompson, D.; Hartmuth, K.; Matzke, M.A.; Matzke, A.J.M. The expression of a nopaline synthase-human growth hormone chimaeric gene in transformed tobacco and sunflower callus tissue. Plant Mol. Biol. 1986, 6, 347-357.
2. Sijmons, P.C.; Dekker, B.M.; Schrammeijer, B.; Verwoerd, T.C.; van den Elzen, P.J.; Hoekema, A. Production of correctly processed human serum albumin in transgenic plants. Nat. Biotechnol. 1990, 8, 217-221.
3. Obembe, O.O.; Popoola, J.O.; Leelavathi, S.; Reddy, S.V. Advances in plant molecular farming. Biotechnol. Adv. 2011, 29, 210-222.
4. Homepage of KEGG: Koto Encyclopedia of Genes and Genomes. Available online: http://www.genome.jp/kegg/ (accessed on 19 May 2011).
5. Homepage of Cytokines & Cells Online Pathfinder Encyclopedia. Available online: http://www.copewithcytokines.org/cope.cgi (accessed on 19 May 2011).
6. Andersson, U.; Tracey, K.J. Molecular basis of applied biological therapeutics. J. Intern. Med. 2011, 269, 2-7.
7. Cutler, A.; Brombacher, F. Cytokine therapy. Ann. N. Y. Acad. Sci. 2005, 1056, 16-29.
8. Tayal, V.; Kalra, B.S. Cytokines and anti-cytokines as therapeutics-an update. Eur. J. Pharmacol. 2008, 579, 1-12.
9. Toka, F.N.; Pack, C.D.; Rouse, B.T. Molecular adjuvants for mucosal immunity. Immunol. Rev. 2004, 199, 100-112.
10. Elias, E.G.; Zapas, J.L.; McCarron, E.C.; Beam, S.L.; Hasskamp, J.H.; Culpepper, W.J. Sequential administration of GM-CSF (Sargramostim) and IL-2 +/- autologous vaccine as adjuvant therapy in cutaneous melanoma: An interim report of a phase II clinical trial. Cancer Biother. Radiopharm. 2008, 23, 285-291.
11. Batista-Duharte, A.; Lindblad, E.B.; Oviedo-Orta, E. Progress in understanding adjuvant immunotoxicity mechanisms. Toxicol. Lett. 2011, 203, 97-105.
12. Williams, P.; Galipeau, J. GMCSF-Interleukin fusion cytokines induce novel immune effectors that can serve as biopharmaceuticals for treatment of autoimmunity and cancer. J. Intern. Med. 2011, 269, 74-84.
13. Matsumoto, S.; Ikura, K.; Ueda, M.; Sasaki, R. Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells. Plant Mol. Biol. 1995, 27, 1163-1172.
14. Hong, S.-Y.; Kwon, T.-H.; Lee, J.-H.; Jang, Y.-S.; Yang, M.-S. Production of biologically active hG-CSF by transgenic plant cell suspension culture. Enzyme Microb. Technol. 2002, 30, 762-767.
15. James, E.A.; Wang, C.; Wang, Z.; Reeves, R.; Shin, J.H.; Magnuson, N.S.; Lee, J.M. Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. Protein Expr. Purif. 2000, 19, 131-138.
16. Lee, J.H.; Kim, N.S.; Kwon, T.H.; Jang, Y.S.; Yang, M.S. Increased production of human granulocyte-macrophage colony stimulating factor (hGM-CSF) by the addition of stabilizing polymer in plant suspension cultures. J. Biotechnol. 2002, 96, 205-211.
17. Shin, Y.J.; Hong, S.Y.; Kwon, T.H.; Jang, Y.S.; Yang, M.S. High level of expression of recombinant human granulocyte-macrophage colony stimulating factor in transgenic rice cell suspension culture. Biotechnol. Bioeng. 2003, 82, 778-783.
18. Kim, N.S.; Kim, T.G.; Jang, Y.S.; Shin, Y.J.; Kwon, T.H.; Yang, M.S. Amylase gene silencing by RNA interference improves recombinant hGM-CSF production in rice suspension culture. Plant Mol. Biol. 2008, 68, 369-377.
19. Kim, N.S.; Kim, T.G.; Kim, O.H.; Ko, E.M.; Jang, Y.S.; Jung, E.S.; Kwon, T.H.; Yang, M.S. Improvement of recombinant hGM-CSF production by suppression of cysteine proteinase gene expression using RNA interference in a transgenic rice culture. Plant Mol. Biol. 2008, 68, 263-275.
20. Kim, T.G.; Lee, H.J.; Jang, Y.S.; Shin, Y.J.; Kwon, T.H.; Yang, M.S. Co-expression of proteinase inhibitor enhances recombinant human granulocyte-macrophage colony stimulating factor production in transgenic rice cell suspension culture. Protein Expr. Purif. 2008, 61, 117-121.
21. Wang, M.L.; Goldstein, C.; Su, W.; Moore, P.H.; Albert, H.H. Production of biologically active GM-CSF in sugarcane: A secure biofactory. Transgenic Res. 2005, 14, 167-178.
22. Sardana, R.K.; Alli, Z.; Dudani, A.; Tackaberry, E.; Panahi, M.; Narayanan, M.; Ganz, P.; Altosaar, I. Biological activity of human granulocyte-macrophage colony stimulating factor is maintained in a fusion with seed glutelin peptide. Transgenic Res. 2002, 11, 521-531.
23. Sardana, R.; Dudani, A.K.; Tackaberry, E.; Alli, Z.; Porter, S.; Rowlandson, K.; Ganz, P.; Altosaar, I. Biologically active human GM-CSF produced in the seeds of transgenic rice plants. Transgenic Res. 2007, 16, 713-721.
24. Ning, T.; Xie, T.; Qiu, Q.; Yang, W.; Zhou, S.; Zhou, L.; Zheng, C.; Zhu, Y.; Yang, D. Oral administration of recombinant human granulocyte-macrophage colony stimulating factor expressed in rice endosperm can increase leukocytes in mice. Biotechnol. Lett. 2008, 30, 1679-1686.
25. Gora-Sochacka, A.; Redkiewicz, P.; Napiorkowska, B.; Gaganidze, D.; Brodzik, R.; Sirko, A. Recombinant mouse granulocyte-macrophage colony-stimulating factor is glycosylated in transgenic tobacco and maintains its biological activity. J. Interferon Cytokine Res. 2010, 30, 135-142.
26. Zhou, F.; Wang, M.L.; Albert, H.H.; Moore, P.H.; Zhu, Y.J. Efficient transient expression of human GM-CSF protein in Nicotiana benthamiana using potato virus X vector. Appl. Microbiol. Biotechnol. 2006, 72, 756-762.
27. Magnuson, N.S.; Linzmaier, P.M.; Reeves, R.; An, G.; HayGlass, K.; Lee, J.M. Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture. Protein Expr. Purif. 1998, 13, 45-52.
28. Park, Y.; Cheong, H. Expression and production of recombinant human interleukin-2 in potato plants. Protein Expr. Purif. 2002, 25, 160-165.
29. Morandini, F.; Avesani, L.; Bortesi, L.; van Droogenbroeck, B.; de Wilde, K.; Arcalis, E.; Bazzoni, F.; Santi, L.; Brozzetti, A.; Falorni, A.; et al. Non-food/feed seeds as biofactories for the high-yield production of recombinant pharmaceuticals. Plant Biotechnol. J. 2011, doi: 10.1111/j.1467-7652.2011.00605.x.
30. Patel, J.; Zhu, H.; Menassa, R.; Gyenis, L.; Richman, A.; Brandle, J. Elastin-like polypeptide fusions enhance the accumulation of recombinant proteins in tobacco leaves. Transgenic Res. 2007, 16, 239-249.
31. Ma, S.; Huang, Y.; Davis, A.; Yin, Z.; Mi, Q.; Menassa, R.; Brandle, J.E.; Jevnikar, A.M. Production of biologically active human interleukin-4 in transgenic tobacco and potato. Plant Biotechnol. J. 2005, 3, 309-318.
32. Menassa, R.; Kennette, W.; Nguyen, V.; Rymerson, R.; Jevnikar, A.; Brandle, J. Subcellular targeting of human interleukin-10 in plants. J. Biotechnol. 2004, 108, 179-183.
33. Fujiwara, Y.; Aiki, Y.; Yang, L.; Takaiwa, F.; Kosaka, A.; Tsuji, N.M.; Shiraki, K.; Sekikawa, K. Extraction and purification of human interleukin-10 from transgenic rice seeds. Protein Expr. Purif. 2010, 72, 125-130.
34. Bortesi, L.; Rossato, M.; Schuster, F.; Raven, N.; Stadlmann, J.; Avesani, L.; Falorni, A.; Bazzoni, F.; Bock, R.; Schillberg, S.; et al. Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco. BMC Biotechnol. 2009, 9, 22.
35. Gutierrez-Ortega, A.; Avila-Moreno, F.; Saucedo-Arias, L.J.; Sanchez-Torres, C.; Gomez-Lim, M.A. Expression of a single-chain human interleukin-12 gene in transgenic tobacco plants and functional studies. Biotechnol. Bioeng. 2004, 85, 734-740.
36. Gutierrez-Ortega, A.; Sandoval-Montes, C.; de Olivera-Flores, T.J.; Santos-Argumedo, L.; Gomez-Lim, M.A. Expression of functional interleukin-12 from mouse in transgenic tomato plants. Transgenic Res. 2005, 14, 877-885.
37. Sanchez-Hernandez, C.; Gutierrez-Ortega, A.; Aguilar-Leon, D.; Hernandez-Pando, R.; Gomez-Lim, M.; Gomez-Garcia, B. In vivo activity of plant-based interleukin-12 in the lung of Balb/c mouse. BMC Res. Notes 2010, 3, 151.
38. Kwon, T.H.; Seo, J.E.; Kim, J.; Lee, J.H.; Jang, Y.S.; Yang, M.S. Expression and secretion of the heterodimeric protein interleukin-12 in plant cell suspension culture. Biotechnol. Bioeng. 2003, 81, 870-875.
39. Wang, D.J.; Brandsma, M.; Yin, Z.; Wang, A.; Jevnikar, A.M.; Ma, S. A novel platform for biologically active recombinant human interleukin-13 production. Plant Biotechnol. J. 2008, 6, 504-515.
40. Zhang, B.; Yang, Y.H.; Lin, Y.M.; Rao, Q.; Zheng, G.G.; Wu, K.F. Expression and production of bioactive human interleukin-18 in transgenic tobacco plants. Biotechnol. Lett. 2003, 25, 1629-1635.
41. Farran, I.; Rio-Manterola, F.; Iniguez, M.; Garate, S.; Prieto, J.; Mingo-Castel, A.M. High-density seedling expression system for the production of bioactive human cardiotrophin-1, a potential therapeutic cytokine, in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2008, 6, 516-527.
42. Ohya, K.; Matsumura, T.; Ohashi, K.; Onuma, M.; Sugimoto, C. Expression of two subtypes of human IFN-alpha in transgenic potato plants. J. Interferon Cytokine Res. 2001, 21, 595-602.
43. Sawahel, W.A. The production of transgenic potato plants expressing human alpha-interferon using lipofectin-mediated transformation. Cell. Mol. Biol. Lett. 2002, 7, 19-29.
44. Arazi, T.; Slutsky, S.G.; Shiboleth, Y.M.; Wang, Y.; Rubinstein, M.; Barak, S.; Yang, J.; Gal-On, A. Engineering zucchini yellow mosaic potyvirus as a non-pathogenic vector for expression of heterologous proteins in cucurbits. J. Biotechnol. 2001, 87, 67-82.
45. Arlen, P.A.; Falconer, R.; Cherukumilli, S.; Cole, A.; Cole, A.M.; Oishi, K.K.; Daniell, H. Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnol. J. 2007, 5, 511-525.
46. Luchakivskaya, Y.; Kishchenko, O.; Gerasymenko, I.; Olevinskaya, Z.; Simonenko, Y.; Spivak, M.; Kuchuk, M. High-level expression of human interferon alpha-2b in transgenic carrot (Daucus carota L.) plants. Plant Cell Rep. 2011, 30, 407-415.
47. Li, J.; Chen, M.; Liu, X.-W.; Zhang, H.-C.; Shen, F.F.; Wang, G.P. Transient expression of an active human interferon-beta in lettuce. Sci. Hortic. 2007, 112, 258-265.
48. Chen, T.L.; Lin, Y.L.; Lee, Y.L.; Yang, N.S.; Chan, M.T. Expression of bioactive human interferon-gamma in transgenic rice cell suspension cultures. Transgenic Res. 2004, 13, 499-510.
49. Song, L.; Zhao, D.G.; Wu, Y.J.; Li, Y. Transient expression of chicken alpha interferon gene in lettuce. J. Zhejiang Univ. Sci. B 2008, 9, 351-355.
50. Fukuzawa, N.; Tabayashi, N.; Okinaka, Y.; Furusawa, R.; Furuta, K.; Kagaya, U.; Matsumura, T. Production of biologically active Atlantic salmon interferon in transgenic potato and rice plants. J. Biosci. Bioeng. 2010, 110, 201-207.
51. Ohya, K.; Itchoda, N.; Ohashi, K.; Onuma, M.; Sugimoto, C.; Matsumura, T. Expression of biologically active human tumor necrosis factor-alpha in transgenic potato plant. J. Interferon Cytokine Res. 2002, 22, 371-378.
52. Potula, H.H.; Kathuria, S.R.; Ghosh, A.K.; Maiti, T.K.; Dey, S. Transient expression, purification and characterization of bioactive human fibroblast growth factor 8b in tobacco plants. Transgenic Res. 2008, 17, 19-32.
53. Daniell, H.; Ruiz, G.; Denes, B.; Sandberg, L.; Langridge, W. Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function. BMC Biotechnol. 2009, 9, 33.
54. Xie, T.; Qiu, Q.; Zhang, W.; Ning, T.; Yang, W.; Zheng, C.; Wang, C.; Zhu, Y.; Yang, D. A biologically active rhIGF-1 fusion accumulated in transgenic rice seeds can reduce blood glucose in diabetic mice via oral delivery. Peptides 2008, 29, 1862-1870.
55. Medrano, J.; Reidy, M.J.; Liu, J.; Ayala, M.; Dolan, M.C.; Cramer, C.L. Rapid system for evaluating bioproduction capacity of complex pharmaceutical proteins in plants. In Methods in Molecular Biology, Recombinant Proteins from Plants; Faye, L., Gomord, V., Eds.; Humana Press: New York, NY, USA, 2009; Volume 483, pp. 41-67.
56. Edelbaum, O.; Stein, D.; Holland, N.; Gafni, Y.; Livneh, O.; Novick, D.; Rubinstein, M.; Sela, I. Expression of active human interferon-beta in transgenic plants. J. Interferon Res. 1992, 12, 449-453.
57. Davies, H.M. Review article: Commercialization of whole-plant systems for biomanufacturing of protein products: Evolution and prospects. Plant Biotechnol. J. 2010, 8, 845-861.
58. Ramessar, K.; Capell, T.; Christou, P. Molecular pharming in cereal crops. Phytochem. Rev. 2008, 7, 579-592.
59. Schillberg, S.; Twyman, R.M.; Fischer, R. Opportunities for recombinant antigen and antibody expression in transgenic plants-technology assessment. Vaccine 2005, 23, 1764-1769.
60. Sharma, A.K.; Sharma, M.K. Plants as bioreactors: Recent developments and emerging opportunities. Biotechnol. Adv. 2009, 27, 811-832.
61. Luo, J.; Ning, T.; Sun, Y.; Zhu, J.; Zhu, Y.; Lin, Q.; Yang, D. Proteomic analysis of rice endosperm cells in response to expression of hGM-CSF. J. Proteome Res. 2009, 8, 829-837.
62. Sparrow, P.A.; Irwin, J.A.; Dale, P.J.; Twyman, R.M.; Ma, J.K. Pharma-Planta: Road testing the developing regulatory guidelines for plant-made pharmaceuticals. Transgenic Res. 2007, 16, 147-161.
63. Spok, A.; Twyman, R.M.; Fischer, R.; Ma, J.K.; Sparrow, P.A. Evolution of a regulatory framework for pharmaceuticals derived from genetically modified plants. Trends Biotechnol. 2008, 26, 506-517.
64. Lutz, K.A.; Maliga, P. Construction of marker-free transplastomic plants. Curr. Opin. Biotechnol. 2007, 18, 107-114.
65. Barampuram, S.; Zhang, Z.J. Recent advances in plant transformation. Methods Mol. Biol. 2011, 701, 1-35.
66. Paul, M.; Ma, J.K. Plant-made pharmaceuticals: Leading products and production platforms. Biotechnol. Appl. Biochem. 2011, 58, 58-67.